Carole Huntsman, Chief Commercial Officer at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 1,376 shares at $316.92 ($436K) on 2024-11-21, disclosed to the SEC on 2024-11-22.
Open-market sale of $436k MDGL by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $316.92 | 688 | $218K | 50.0% |
| 2 | $316.92 | 688 | $218K | 50.0% |
| Total | $316.92 avg | 1,376 | $436K | 100% |
| Filing → |
| MDGL | SELL | 2025-11-21 | $1.8M | — | Filing → |
| MDGL | SELL | 2025-03-05 | $727K | — | Filing → |
| MDGL | SELL | 2025-01-27 | $233K | — | Filing → |